Overview of Dr. Schrag
Dr. Deborah Schrag is an oncologist in New York, NY and is affiliated with multiple hospitals in the area, including Memorial Sloan Kettering Cancer Center, Dana-Farber Cancer Institute, and Brigham and Women's Hospital. She received her medical degree from Columbia University Vagelos College of Physicians and Surgeons and has been in practice 26 years. Dr. Schrag accepts several types of health insurance, listed below. She is one of 455 doctors at Dana-Farber Cancer Institute and one of 377 doctors at Brigham and Women's Hospital who specialize in Oncology. She has more than 100 publications and over 500 citings.
Office
1919 Madison Avenue
(Entrance on 124th Street)
New York, NY 10035
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1994 - 1997
- Brigham and Women's HospitalResidency, Internal Medicine, 1991 - 1994
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1991
Certifications & Licensure
- NY State Medical License 1998 - 2027
- MA State Medical License 1993 - 2025
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- American Association of Physicians 2016
- Fellow (FASCO) American Society of Clinical Oncologists, 2012
- Super Doctor SuperDoctors.com
Clinical Trials
- PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Start of enrollment: 2012 Jun 12
- Symptom Management Implementation of Patient Reported Outcomes in Oncology Start of enrollment: 2019 Jul 25
- Assessment of the Implementation of an Investigational Multi-Cancer Early Detection Test Into Clinical Practice Start of enrollment: 2019 Dec 12
Publications & Presentations
PubMed
- Incidence of patient-reported fatigue developing on palbociclib and endocrine therapy for advanced HR+ HER2- breast cancer.Shadab A Rahman, Hanneke Poort, Deborah Schrag, Stephanie C Tung, Eric S Zhou
The Oncologist. 2024-12-19 - Predictors of recurrent venous thromboembolism and major bleeding in patients with cancer: A secondary analysis of the CANVAS trial.Hajime Uno, Hong Xiong, Christine Cronin, Deborah Schrag, Jean M Connors
Thrombosis Research. 2024-12-01 - 1 citationsAutomated real-world data integration improves cancer outcome prediction.Justin Jee, Christopher Fong, Karl Pichotta, Thinh Ngoc Tran, Anisha Luthra
Nature. 2024-12-01
Journal Articles
- Effectiveness of a Multimedia Educational Intervention to Improve Understanding of the Risks and Benefits of Palliative Chemotherapy in Patients with Advanced CancerAndrea C Enzinger, Hanna Sanoff, Deborah Schrag, JAMA Oncology
- Oncology in TransitionEthan Basch, Deborah Schrag, JAMA
Authored Content
- Lack of Association Between Heart Failure and Incident CancerApril 2018
Press Mentions
- AACR Annual Meeting 2023: Opening Plenary Covers Breadth of Cancer ResearchApril 25th, 2023
- Could a Blood Test Effectively Screen for Cancers?September 20th, 2022
- Screening Blood Test for 50 Cancers Shows Promise, But False-Positives HighSeptember 11th, 2022
- Join now to see all
Professional Memberships
- Fellow
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
BCBS Blue Card PPO
BCBS Illinois Blue Advantage HMO
BCBS Illinois BlueChoice Select
BCBS Illinois HMO
BCBS Illinois PPO
BCBS Massachusetts Blue Care Elect PPO
CIGNA HMO
CIGNA Open Access
CIGNA PPOFirst Health PPO
Great West PPO
Harvard Pilgrim HMO
HealthLink PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
Tufts Health Plan PPO
UniCare PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: